SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Analysts and calls -- Salomon Smith Barney
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Icebrg who started this subject1/12/2003 7:40:26 PM
From: Mike   of 3
 
Looking to get some discussion going on this biotech that has great promise. The best thing is that it has an FDA approved product that may double in sales in '03. The company is MDCO-The Medicine Company. The product they have is called Angiomax.

First, I would like to try to revive the MDCO board here. MDCO has delivered and has hit a homerun in 2002. It completed and presented results on the Angiomax product just last month. All primary and secondary endpoints of the trial were met. Sales for '02 ended with a high note. Earnings for Q4 '02 will released in early Feb. Sales for '02 will be in the $38M range. From the sources that I have in the field it has been estimated that November '02 were a record of approx $4M. The sales for Dec '02 were in the range of $5M.

Projections have been made for '03 during the conference listed below.

mapdigital.com.

During this conference the company stated that sales for '03 would be in the $70-$90M range. This could be over a 100% increase!!!

I think that this company is a "diamond in the rough". It is followed by very few analyst and needs more exposure. I think longs will be rewarded handsomely if the company executes. Take a look and let us know what you think.

Thanks in advance,
Mike
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2024 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News